Cancer Treatment Decision Journey Study
Understand how cancer patients and caregivers evaluate treatment options, compare hospitals and specialists, and navigate cost, access, side effects, and clinical advice, so you can strengthen patient acquisition, service positioning, referral strategy, and retention.
CONTEXT & RELEVANCE
Why run this survey now
Most cancer care providers don't lose treatment consideration purely on reputation. They lose patients due to referral friction, affordability concerns, side-effect fears, travel burden, and unclear care pathways, none of which show up in satisfaction scores or discharge feedback.
If you are...
- Oncology business leadership
- Patient experience teams
- Hospital growth strategists
- Clinical service line heads
RESEARCH THEMES
What This Survey Investigates
Eight interconnected research themes that map the complete cancer treatment decision journey from diagnosis to follow-up.
Diagnosis & Urgency
- Diagnosis source and certainty
- Treatment urgency and readiness
Information & Guidance
- Trusted information sources
- Clinical guidance clarity
Provider & Specialist
- Hospital consideration criteria
- Specialist trust signals
Treatment Trade-offs
- Clinical benefit expectations
- Side-effect acceptance thresholds
Access & Affordability
- Travel and appointment friction
- Coverage and payment burden
Caregiver & Support
- Caregiver decision influence
- Practical support needs
Initiation & Experience
- Pre-treatment pathway friction
- Active care experience
Follow-up & Loyalty
- Continuity and follow-up adherence
- Advocacy and provider loyalty
SAMPLING STRATEGY
Tell us about your ideal sample
Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.
METHODOLOGY
Survey approach
For Cancer Treatment Decision Journey Study, we recommend a patient-and-caregiver-led mixed quantitative approach with flexible data-collection modes to balance reach, depth, and verification across diagnosis stages, care settings, and treatment statuses.
EXECUTION PROCESS
How we execute
A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.
Define the decision frame
Confirm objectives, target cohorts, geographies, and reporting cuts
Define the decision frame
Design the instrument
Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)
Design the instrument
Lock the questionnaire
Review wording, sequencing, LOI, and competitive context; approve final version
Lock the questionnaire
Pilot and calibrate
Test comprehension and ease quality; refine quotas and remove friction where needed
Pilot and calibrate
Run fieldwork
Execute collection with active quota management and feasibility controls
Run fieldwork
Assure quality
Dedupe, attention checks, speed/consistency rules, removals with audit trail
Assure quality
Prepare the dataset
Clean data and deliver codebook/variable definitions
Prepare the dataset
Analyse and synthesise
Driver ranking, leakage diagnostics, pricing bands, segment insights
Analyse and synthesise
Deliver and align
Executive deck (optional dashboard) and leadership readout with recommendations
Deliver and align
COMMERCIAL TERMS
Request a Commercial Proposal
Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.
Select Sample Size
Geography
Select Mode of Survey
Length of the Interview
$0.00
+ applicable taxes
Cost Breakdown
Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.
REFERENCE CASELETS
Reference
Real-world examples of survey work in the oncology and cancer-care space.
Oncology Centre Brand Consideration Drivers Across Metro Markets (India)
OBJECTIVE
WHAT WE DID
DELIVERED
Oncology Centre Brand Consideration Drivers Across Metro Markets (India)
Support Service Package Design for Chemotherapy Patients (India)
Oncology Centre Brand Consideration Drivers Across Metro Markets (India)
OBJECTIVE
A pan-India hospital network needed to understand how newly diagnosed patients , primary caregivers , and referring families compared specialist credentials , hospital reputation, proximity, and treatment coordination when shortlisting oncology centres across six metropolitan markets.
WHAT WE DID
We conducted a structured online survey with 720 patients and caregivers , using city, cancer-type, and diagnosis-stage quotas to capture awareness sources , referral influence, consideration sets, provider trade-offs, and reasons for excluding shortlisted centres.
DELIVERED
The study produced a brand consideration funnel , provider preference map , city-level message territories , and a ranked channel levers framework linking referral sources, information needs, and service proof points to distinct audience segments.
FREQUENTLY ASKED QUESTIONS
Common Questions
Answers to frequently asked questions about this survey mandate.
What decisions will this survey enable?
Who is the buyer vs who are the respondents?
Can we see differences between early-stage, locally advanced and metastatic patients?
How will you measure treatment preference beyond simple ratings?
Will the survey map the full cancer treatment journey and drop-offs?
Can this survey inform product and pricing strategy?
How will findings improve our oncology patient acquisition strategy?
Still have questions?
Schedule a discovery call to discuss your specific needs and get a custom quote.